30.04.2020 • News

BASF Retracts 2020 Earnings Estimate

BASF has retracted its earnings estimate for 2020 communicated at the end of February, citing a clouded outlook amid the coronavirus pandemic. “In any case, the Feb. 28 forecast will not be met,” it said.

BASF Retracts 2020 Earnings Estimate (c) BASF
BASF Retracts 2020 Earnings Estimate (c) BASF

As it is “currently impossible to reliably estimate both the length and the further spread of the coronavirus pandemic, as well as future measures to contain it,“ the German group, world’s largest chemical producer, said “concrete statements on the development of sales and earnings in 2020 cannot be made at present.”

The shareholders’ dividend for 2019 nevertheless will remain unchanged at €3.30 per share, provided the annual general meeting on Jun. 23 approves management’s proposals.

At its annual results press conference, BASF forecast a rise in sales to €60-63 billion in 2020, up from €59.3 billion in 2019, and EBIT before special items of €4.2-4.8 billion, in the range of the €4.5 billion posted in 2019.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read